Researchers use AI-powered database to design potential cancer drug in 30 days
In less than a month, researchers have used AlphaFold, an artificial intelligence (AI)-powered protein structure database, to design and synthesize a potential drug to treat hepatocellular carcinoma (HCC), the most common type of primary liver cancer.
Source: utoronto.ca